Drug reference
amlodipine-olmesartan
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Cardiovascular (Combination(CVS))
Mechanism of action
Amlodipine: Ca channel blocker; inhibits the transmembrane influx of extracellular Ca ions across the membranes of myocardial cells and vascular smooth muscle cells. Omlesartan: Blocks binding of angiotensin II to type 1 angiotensin II receptors, causing a lowering in blood pressure; blocks vasoconstrictor and aldosterone-secreting effects
Common side effects
- Orthostatic hypotension
- Palpitation
- Nocturia
- Urinary frequency
- Peripheral edema
Boxed warnings
- Discontinue as soon as possible when pregnancy is detected; affects renin-angiotensin system causing oligohydramnios, which may result in fetal injury and/or death
Contraindications
- Hypersensitivity to olmesartan, amlodipine or excipients Coadministration with aliskiren in patients with diabetes mellitus
Known interactions (1)
- amlodipine-olmesartan + dantrolene Moderate
Related conditions
Frequently asked questions
What drug class is amlodipine-olmesartan?
amlodipine-olmesartan belongs to: Cardiovascular.
How does amlodipine-olmesartan work?
Amlodipine: Ca channel blocker; inhibits the transmembrane influx of extracellular Ca ions across the membranes of myocardial cells and vascular smooth muscle cells. Omlesartan: Blocks binding of angiotensin II to type 1 angiotensin II receptors, causing a lowering in blood pressure; blocks vasoconstrictor and aldosterone-secreting effects
What are the common side effects of amlodipine-olmesartan?
Orthostatic hypotension, Palpitation, Nocturia, Urinary frequency, Peripheral edema
Which drugs interact with amlodipine-olmesartan?
dantrolene
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.